Honeywell
HON
$211.41
+0.43%
Honeywell International is a global multi-industry industrial conglomerate operating through four segments — Aerospace Technologies, Building Automation, Process Automation and Technology, and Industrial Automation — with roughly one-third of revenue derived from recurring aftermarket services across a vast installed base of equipment. The company is a legacy industrial blue chip with deep engineering moats and mission-critical positions in aerospace and process automation, but its identity is being deliberately reshaped: management has completed the spin-off of Honeywell Aerospace as a standalone entity, leaving the remaining HON as a leaner, automation-and-sustainability-focused pure play. The investor narrative is now dominated by the structural shakeup — headlines such as "Honeywell Is Now Three Companies" and "Is Honeywell Stock a Buy After Its Latest Structural Shakeup?" frame the debate around whether the sum-of-the-parts unlock creates value, with bulls pointing to pure-play automation demand and AI tailwinds while skeptics flag the disappointing standalone Aerospace debut (a 32% pro forma earnings decline) and uncertainty about the remaining company's growth profile. Near-term sentiment has been further complicated by a revenue decline in the most recent quarter and a stock that has lagged the broader market over the past six months, leaving investors weighing transformation upside against execution risk.…
HON
Honeywell
$211.41
Related headlines
Investment Opinion: Should I buy HON Today?
HON receives a Hold rating with a balanced risk/reward profile. The analyst consensus is Buy (mean 2.0) with an average target of $254.91, implying 20.6% upside, but near-term fundamentals are weak, with revenue declining 6.1% and the stock significantly underperforming the market. The core thesis is that the spin-off transformation will eventually unlock value, but execution risks and margin pressure warrant caution until clearer signs of stabilization emerge.
Supporting evidence includes a forward P/E of 21.5x, which is reasonable for a high-quality industrial with a 30.6% ROE and 17.5% operating margin. Free cash flow of $4.12 billion and a 4.55% dividend yield provide income and downside support. However, revenue growth is negative (-6.1% YoY), gross margin has contracted to 37.6%, and debt-to-equity is elevated at 2.24x. The stock trades at 1.75x sales and 10.7x EV/EBITDA, which is not demanding but reflects the current earnings uncertainty.
The biggest risks are continued revenue decline, failure to improve margins, and the overhang from the Aerospace spin-off's weak debut. The rating would upgrade to Buy if revenue growth turns positive and gross margin stabilizes above 38%, or if the stock pulls back to the $195-200 range (near 52-week low) offering a better risk/reward. It would downgrade to Sell if revenue declines accelerate or if debt levels rise further. Relative to its own history and peers, HON appears fairly valued to slightly undervalued on a forward basis, but the lack of near-term catalysts justifies a Hold.
Sign up to view all
HON 12-Month Price Forecast
HON presents a balanced risk/reward profile with a neutral stance. The company's transformation into a pure-play automation business offers long-term upside, but near-term fundamentals are weak, with revenue declines and margin pressure. The analyst consensus is bullish, but the stock's relative underperformance and execution risks warrant caution. An upgrade to bullish would require evidence of revenue re-acceleration and margin stabilization, while a downgrade to bearish would follow further deterioration in financials or a failed spin-off integration.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Honeywell's 12-month outlook, with a consensus price target around $254.91 and implied upside of +20.6% versus the current price.
Average Target
$254.91
0 analysts
Implied Upside
+20.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$186 - $303
Analyst target range
Bulls vs Bears: HON Investment Factors
The bull case rests on HON's transformation into a focused automation pure play, strong profitability, and a compelling 20.6% upside to analyst targets, supported by a low beta and high dividend yield. However, the bear case has stronger near-term evidence: revenue is declining (-6.1% YoY), margins are contracting, leverage is high (D/E 2.24), and the stock has significantly underperformed the market (-17% relative strength over 6 months). The most important tension is whether the spin-off will unlock value through multiple expansion and growth acceleration, or whether the remaining company will struggle with slower growth and execution risk. Resolving this debate requires evidence of revenue re-acceleration and margin stabilization in the coming quarters.
Bullish
- Analyst consensus Buy with 20.6% upside: All 23 analysts covering HON rate it a Buy (recommendation mean 2.0) with an average target price of $254.91, implying 20.6% upside from the current $211.41. The high target of $303 suggests 43.3% upside, indicating strong conviction among the most bullish analysts.
- Attractive forward valuation at 21.5x: HON trades at a forward P/E of 21.5x based on estimated EPS of $12.76, which is reasonable for a high-quality industrial with a 30.6% ROE and 17.5% operating margin. The trailing P/E of 13.8x is distorted by one-time gains but highlights the earnings power of the remaining automation-focused business.
- Strong profitability and cash generation: The company generated $4.12 billion in trailing free cash flow and maintains a 12.6% net margin, 17.5% operating margin, and 36.9% gross margin. ROE of 30.6% and ROA of 5.7% demonstrate efficient capital deployment despite the portfolio restructuring.
- Spin-off unlocks pure-play automation value: The completed Aerospace spin-off leaves HON as a leaner automation and sustainability pure play, with roughly one-third of revenue from recurring aftermarket services. Management's focus on secular growth trends like AI and building automation could drive multiple expansion as the market re-rates the simplified story.
Bearish
- Revenue decline and margin pressure: Q2 2026 revenue fell 6.1% year-over-year to $9.72 billion, and gross margin contracted to 37.6% from 38.9% a year earlier. The top-line weakness raises questions about the growth profile of the remaining businesses post-spin-off.
- High leverage constrains flexibility: Debt-to-equity stands at 2.24x, which is elevated for an industrial company and could limit strategic options or increase vulnerability if rates remain high. Interest expense of $363 million in Q2 alone consumes a meaningful portion of operating income.
- Relative underperformance and weak momentum: HON has lagged the S&P 500 significantly, with a 6-month relative strength of -17.0% and a 3-month relative strength of -8.7%. The stock is down 9.5% over six months versus a 7.5% gain for the SPY, indicating negative sentiment and institutional selling.
- Aerospace spin-off debut disappoints: The newly independent Honeywell Aerospace reported a 32% pro forma earnings decline in its first quarter, which could taint the market's perception of the spin-off's value and raise doubts about management's execution. This overhang may weigh on HON shares as investors reassess the sum-of-the-parts.
HON Technical Analysis
Beta
0.89
0.89x market volatility
Max Drawdown
-19.1%
Largest decline past year
52-Week Range
$196-$260
Price range past year
Annual Return
+10.4%
Cumulative gain past year
| Period | HON Return | S&P 500 |
|---|---|---|
| 1m | +1.8% | +0.2% |
| 3m | -6.0% | +2.9% |
| 6m | -9.5% | +8.4% |
| 1y | +10.4% | +14.9% |
| ytd | +7.9% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
HON Fundamental Analysis
Quarterly Revenue
$9.7B
2026-06
Revenue YoY Growth
-6.1%
YoY Comparison
Gross Margin
37.6%
Latest Quarter
Free Cash Flow
$4.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is HON Overvalued?
PE
13.8x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 9x~17x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.7x
Enterprise Value Multiple
Investment Risk Disclosure
HON faces financial risks from its elevated debt load, with a debt-to-equity ratio of 2.24x and $363 million in quarterly interest expense that consumes a meaningful share of operating income. The company's revenue declined 6.1% year-over-year in Q2 2026 to $9.72 billion, and gross margin contracted to 37.6% from 38.9%, indicating pressure on profitability. Additionally, Q2 2026 net income was inflated by a $5.79 billion one-time other income item, masking underlying earnings quality and creating uncertainty about sustainable EPS. The 62.9% payout ratio leaves little room for dividend growth if earnings decline further.
Market and competitive risks include HON's significant underperformance versus the S&P 500, with a 6-month relative strength of -17.0% and a 3-month relative strength of -8.7%, reflecting negative investor sentiment. The stock's beta of 0.888 offers some defense, but sector rotation away from industrials could exacerbate declines. The disappointing standalone performance of Honeywell Aerospace, which reported a 32% pro forma earnings decline in its first quarter, raises questions about the value unlocked by the spin-off and could pressure HON if the market extrapolates weakness to the remaining businesses. Competitive threats in automation from peers like Siemens and Rockwell could limit pricing power.
In a worst-case scenario, a continued revenue decline, margin compression, and failure to realize spin-off synergies could drive the stock toward its 52-week low of $195.87, representing a 7.4% decline from the current $211.41. If analyst bear-case target of $186 is reached, the downside would be 12.0%. A more severe scenario involving a recession and multiple compression could push shares below $180, a 15% drop. The maximum drawdown over the past period was -19.1%, suggesting that a decline to around $171 could occur in a broad market selloff, representing a 19% loss from current levels.
FAQ
The most severe risk is financial: revenue is declining 6.1% YoY and gross margins have contracted to 37.6%, which could pressure earnings. High debt-to-equity of 2.24x adds financial risk, with $363 million in quarterly interest expense. Competitive risks include intense pressure in automation from peers like Siemens and Rockwell, which could limit pricing power. Macro risks include a potential industrial recession, which would hit HON's cyclical end markets. Company-specific risks center on the Aerospace spin-off's weak debut (32% pro forma earnings decline) and whether management can successfully execute the remaining transformation.
Our 12-month forecast has three scenarios: a bull case (25% probability) targeting $255-303, a base case (55% probability) targeting $210-255, and a bear case (20% probability) targeting $186-196. The base case is most likely, assuming revenue stabilizes and margins hold near current levels, with the stock trading around the analyst average target of $254.91. The key assumption is that the company returns to low single-digit growth and avoids further margin deterioration. Upside would require successful execution of the spin-off and a rebound in automation demand.
HON appears fairly valued to slightly undervalued on a forward basis. The forward P/E of 21.5x is reasonable for a high-quality industrial with a 30.6% ROE, and the EV/EBITDA of 10.7x is in line with historical averages. The trailing P/E of 13.8x is distorted by one-time gains, while the price-to-sales ratio of 1.75x is modest. Compared to peers, HON trades at a discount to premium automation names but at a premium to slower-growing conglomerates. The market appears to be pricing in modest growth and successful execution of the spin-off, with upside if margins improve.
HON offers a mixed risk/reward profile. On the positive side, analysts have a Buy consensus with an average target of $254.91, implying 20.6% upside, and the stock pays a 4.55% dividend yield. However, revenue is declining 6.1% year-over-year, gross margins are contracting, and the stock has underperformed the S&P 500 by 17% over six months. The biggest downside risk is a continued decline toward the 52-week low of $195.87, about 7% below current levels. For long-term income investors, the dividend and low beta (0.888) may be attractive, but near-term uncertainty suggests waiting for clearer signs of stabilization before buying aggressively.
HON is better suited for long-term investment, given its low beta (0.888), 4.55% dividend yield, and the multi-year transformation story. Short-term trading is less attractive due to the lack of near-term catalysts and the stock's recent underperformance. The spin-off benefits and automation secular trends will take time to materialize, so a minimum holding period of 2-3 years is recommended to ride out the current uncertainty. Income-focused investors may appreciate the dividend, while growth investors should wait for clearer signs of revenue acceleration before committing capital.